IDEAYA BIOSCIENCES INC Share Price Today: Live Updates & Key Insights
IDEAYA BIOSCIENCES INC share price today is $32.75, up 0.46%. The stock opened at $32.6 against the previous close of $32.6, with an intraday high of $33.46 and low of $32.1875.
IDEAYA BIOSCIENCES INC Share Price Chart
IDEAYA BIOSCIENCES INC
IDEAYA BIOSCIENCES INC Share Price Performance
IDEAYA BIOSCIENCES INC Institutional Holdings
IDEAYA BIOSCIENCES INC Market Status
IDEAYA BIOSCIENCES INC Fundamentals
Market Cap 2875.91 M
PB Ratio 2.7986
PE Ratio 0.0
Enterprise Value 2251.26 M
Total Assets 1109.32 M
Volume 2403041
IDEAYA BIOSCIENCES INC Company Financials
About IDEAYA BIOSCIENCES INC & investment objective
Company Information IDEAYA Biosciences, Inc., a precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selective protein kinase C (PKC) inhibitor for the treatment of uveal melanoma, ocular cancer driven by GNAQ/11 mutations, and is being evaluated in multiple clinical trials as monotherapy and in combination with crizotinib for metastatic, neoadjuvant, and adjuvant settings. The company also offers IDE849, a DLL3 antibody drug conjugate inhibitor that is in a Phase 1 clinical trial for the treatment of SCLC and neuroendocrine carcinomas; IDE034, a B7H3/PTK7 topo-I-payload bispecific BsADC; IDE161, a poly ADP-ribose glycohydrolase inhibitor that is in Phase 1 dose optimization trial; IDE705 (GSK101), a Poly Theta Helicase inhibitor that is in Phase 1 clinical trial for the treatment of tumors with BRCA or other mutations associated with HRD; IDE397, a MAT2A inhibitor for MTAP-deleted tumors; IDE892, a PRMT5 inhibitor; IDE574 selectively inhibits KAT6/7 and is in Phase 1 dose escalation trial for patients with breast, lung, prostate, and colorectal cancers; IDE275 oral small molecule inhibitor of the helicase domain of the Werner protein (WRN) and is in a Phase 1 clinical trial. In addition, the company offers preclinical research programs focused on pharmacological inhibition; DECIPHER dual CRISPR library for synthetic lethality target and biomarker discovery; and INQUIRE chemical library and HARMONY machine-learning engines to enhance its drug discovery platform. The company has strategic alliances with GlaxoSmithKline, Pfizer Inc., Gilead Sciences, Inc., Novartis, Biocytogen, Cancer Research UK, the University of Manchester, Jiangsu Hengrui Pharmaceuticals Co., Ltd., and Les Laboratoires Servie. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Organisation Biotechnology
Employees 145
Industry Biotechnology
CEO Mr. Yujiro S. Hata
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
IDEAYA BIOSCIENCES INC FAQs
What is the share price of IDEAYA BIOSCIENCES INC today?
The current share price of IDEAYA BIOSCIENCES INC is $32.75.
Can I buy IDEAYA BIOSCIENCES INC shares in India?
Yes, Indian investors can buy IDEAYA BIOSCIENCES INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy IDEAYA BIOSCIENCES INC shares in India?
You can easily invest in IDEAYA BIOSCIENCES INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy IDEAYA BIOSCIENCES INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of IDEAYA BIOSCIENCES INC.
Can I buy fractional shares of IDEAYA BIOSCIENCES INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of IDEAYA BIOSCIENCES INC?
IDEAYA BIOSCIENCES INC has a market cap of $2875.91 M.
In which sector does IDEAYA BIOSCIENCES INC belong?
IDEAYA BIOSCIENCES INC operates in the Biotechnology sector.
What documents are required to invest in IDEAYA BIOSCIENCES INC stocks?
To invest, you typically need:
What is the PE and PB ratio of IDEAYA BIOSCIENCES INC?
The PE ratio of IDEAYA BIOSCIENCES INC is N/A and the PB ratio is 2.80.